Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05768295 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multicentric Observational Study Confirming the Performance and Safety of the Axiom® BL X3 Implants

Study acronym: Prospective_X3
StatusActive, Not Recruiting
PhaseNot applicable
SponsorAnthogyr
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 19, 2025 (before its estimated August 20, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Dec 20, 2024 to Aug 20, 2025v4
  2. Trial status: Recruiting to Active, Not Recruiting
    • Study sites: 11 to 13
    v3
  3. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 11
    • Start date changed from estimate of Mar 15, 2023 to Apr 5, 2023
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Anthogyr
2 trials monitored
See all monitored trials
This Post-Market Clinical Follow-Up study aims to document the success and survival of the Axiom® BL X3 Implants up to 3 years after loading.
Trial Details
NCT Number NCT05768295
Lead Sponsor Anthogyr
Conditions
(from sponsor)		 Surgical Operation, Edentulous Jaw, Edentulous Mouth, Implant
Related terms Jaw, Edentulous, Mouth, Edentulous
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov